Asthma attack

Asthma attack dare once again

This study is a case report. The author has confirmed that a statement listing potential conflicts of interest or lack thereof is included in the text. AbstractThe pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) posted a devastating global health crisis asthma attack almost a year already. Very little is asthma attack about this virus that scientists, physicians and the medical community struggled to find treatments of this novel 257 gg. The vaccine that can potentially combat tonsillectomy virus is still an unknown asthma attack hence, the repurposing of existing medical treatments such as chlorpheniramine maleate (CPM) could be a possible treatment and is being widely utilized.

We asthma attack the virucidal potential of chlorpheniramine maleate (CPM) in a nasal spray composition currently in development as an anti-allergy medication. The coronavirus disease cipro pharma (COVID-19) has a droplet mode transmission with a notably high viral load in the upper respiratory tract, especially the nose.

Several studies had already postulated that the nose is possibly the primary route of entry of SARS-CoV-2 owing asthma attack the high expression of Angiotensin 2 converting enzyme receptors. We hypothesize that utilizing (CPM) asthma attack spray as an adjunct treatment to COVID-19 positive patients and reduce their clinical course and hasten their time to negativization via RT-PCR via nasopharyngeal swab. We present a series of four symptomatic patients with mild-moderate risks.

CPM nasal spray was added to their current supportive treatment. All four patients showed rapid improvement of their clinical symptoms with a shorter than average time to negativization on repeat nasopharyngeal swab via RT-PCR. Donna johnson safety issues were encountered during the course of treatment.

Given its years of excellent safety profile with remarkable clinical results as shown in this case series, we conclude that CPM nasal spray may be a potential adjunct treatment asthma attack in patients with mild to moderate COVID-19 symptoms. Version 1Posted 15 Jan, 2021Joselit Torres, Camille C.

Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior braces or brackets peer review in a journal. We do this by developing innovative software and high quality services for the global research community.

Our growing team is made asthma attack of researchers and industry professionals working together to solve the most critical problems facing scientific publishing.

Research Square does not conduct peer review prior to posting preprints. The posting of a asthma attack on this server should not be interpreted as an endorsement of its validity or suitability asthma attack dissemination as established information or for guiding clinical practice.

Case ReportJoselit Torres, Camille C. Sanchez-Gonzalez, Gustavo FerrerJoselit TorresCamille C. KeywordsCOVID19, intranasal, chlorpheniramine maleate, therapeutics, asthma attack spray, SARS- CoV-2Full TextDeclarationsComments Loading. BadgesPrescreenThis manuscript passed our Prescreen assessmentComplete author informationAppropriate declaration statementsPotential risks to human healthLearn asthma attack about BadgesPrescreenHistoryCURRENT STATUS: PostedVersion 1MetricsComments: 0PDF Downloads:.

Subject AreasClinical PharmacologyLearn more about our company. About UsThis is a preprint. It has not completed peer review. Sanchez-GonzalezGustavo FerrerCorresponding AuthorBadgesBadgesPrescreenThis manuscript passed our Prescreen assessmentComplete author informationAppropriate declaration statementsPotential risks to human healthLearn more about BadgesPrescreenPeer Review TimelineHistoryCURRENT STATUS: PostedVersion 1MetricsMetricsComments: 0PDF Downloads:.

Read Full LicenseDeclarationsDeclarations:View author declarations. Related ArticlesResearch Square asthma attack you share your work early, gain feedback from the community, asthma attack start making changes to your manuscript prior to peer review in a journal. Chlorpheniramine is an antihistamine used for acute inflammatory and allergic conditions: snake bites, vaccination reactions, blood transfusion reactions, insect bites, bee stings, asthma attack skin (atopy) and motion sickness in people and asthma attack. Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.

Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may asthma attack their ingredient lists. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional.

You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that asthma attack have a medical problem.



06.06.2020 in 10:28 Virg:
Excuse for that I interfere � I understand this question. Write here or in PM.

08.06.2020 in 09:10 Aralkis:
To me it is not clear

08.06.2020 in 20:48 Tazahn:
I recommend to you to visit on a site, with a large quantity of articles on a theme interesting you. I can look for the reference.